These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

341 related articles for article (PubMed ID: 25443890)

  • 1. Mutant prevention concentrations of colistin used in combination with other antimicrobial agents against Acinetobacter baumannii, Klebsiella pneumoniae and Pseudomonas aeruginosa clinical isolates.
    Choi MJ; Park YK; Peck KR; Ko KS
    Int J Antimicrob Agents; 2014 Nov; 44(5):475-6. PubMed ID: 25443890
    [No Abstract]   [Full Text] [Related]  

  • 2. Mutant prevention concentrations of colistin for Acinetobacter baumannii, Pseudomonas aeruginosa and Klebsiella pneumoniae clinical isolates.
    Choi MJ; Ko KS
    J Antimicrob Chemother; 2014 Jan; 69(1):275-7. PubMed ID: 23997018
    [No Abstract]   [Full Text] [Related]  

  • 3. Containment of carbapenem resistance rates of Klebsiella pneumoniae and Acinetobacter baumannii in a Greek hospital with a concomitant increase in colistin, gentamicin and tigecycline resistance.
    Meletis G; Oustas E; Botziori C; Kakasi E; Koteli A
    New Microbiol; 2015 Jul; 38(3):417-21. PubMed ID: 26147150
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pandrug-resistant Klebsiella pneumoniae, Pseudomonas aeruginosa and Acinetobacter baumannii infections: characteristics and outcome in a series of 28 patients.
    Falagas ME; Rafailidis PI; Matthaiou DK; Virtzili S; Nikita D; Michalopoulos A
    Int J Antimicrob Agents; 2008 Nov; 32(5):450-4. PubMed ID: 18768302
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevalence and 30-day all-cause mortality of carbapenem-and colistin-resistant bacteraemia caused by Acinetobacter baumannii, Pseudomonas aeruginosa, and Klebsiella pneumoniae: Description of a decade-long trend.
    Balkhair A; Al-Muharrmi Z; Al'Adawi B; Al Busaidi I; Taher HB; Al-Siyabi T; Al Amin M; Hassan KS
    Int J Infect Dis; 2019 Aug; 85():10-15. PubMed ID: 31100418
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In-vitro bactericidal activity of colistin against biofilm-associated Pseudomonas aeruginosa and Acinetobacter baumannii.
    Cai Y; Wang R; Liang BB; An MM
    J Hosp Infect; 2009 Aug; 72(4):368-70. PubMed ID: 19443079
    [No Abstract]   [Full Text] [Related]  

  • 7. Epidemiology and antibiotic resistance in a large Italian teaching hospital.
    Esposito S; Pascale R; Esposito I; Noviello S; Russo E; Simone GD; Vitolo M; Rega MR; Massari A
    J Chemother; 2015 Jun; 27(3):163-6. PubMed ID: 24625286
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro activities of non-traditional antimicrobials alone or in combination against multidrug-resistant strains of Pseudomonas aeruginosa and Acinetobacter baumannii isolated from intensive care units.
    Timurkaynak F; Can F; Azap OK; Demirbilek M; Arslan H; Karaman SO
    Int J Antimicrob Agents; 2006 Mar; 27(3):224-8. PubMed ID: 16464562
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Surveillance of antimicrobial susceptibility among bacterial isolates from intensive care unit patients of a tertiary-care university hospital in Iran: 2006-2009.
    Mohammadtaheri Z; Pourpaki M; Mohammadi F; Namdar R; Masjedi MR
    Chemotherapy; 2010; 56(6):478-84. PubMed ID: 21099220
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preservation of Acquired Colistin Resistance in Gram-Negative Bacteria.
    Lee JY; Choi MJ; Choi HJ; Ko KS
    Antimicrob Agents Chemother; 2016 Jan; 60(1):609-12. PubMed ID: 26459897
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Isolation of seven distinct carbapenemase-producing Gram-negative organisms from a single patient.
    Creighton J; Heffernan H; Howard J
    J Antimicrob Chemother; 2017 Jan; 72(1):317-319. PubMed ID: 27621176
    [No Abstract]   [Full Text] [Related]  

  • 12. In vitro susceptibility to various antibiotics of colistin-resistant gram-negative bacterial isolates in a general tertiary hospital in Crete, Greece.
    Samonis G; Matthaiou DK; Kofteridis D; Maraki S; Falagas ME
    Clin Infect Dis; 2010 Jun; 50(12):1689-91. PubMed ID: 20482269
    [No Abstract]   [Full Text] [Related]  

  • 13. Activity of doripenem with and without levofloxacin, amikacin, and colistin against Pseudomonas aeruginosa and Acinetobacter baumannii.
    Pankuch GA; Seifert H; Appelbaum PC
    Diagn Microbiol Infect Dis; 2010 Jun; 67(2):191-7. PubMed ID: 20338710
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro activity of the siderophore monosulfactam BAL30072 against contemporary Gram-negative pathogens from New York City, including multidrug-resistant isolates.
    Landman D; Singh M; El-Imad B; Miller E; Win T; Quale J
    Int J Antimicrob Agents; 2014 Jun; 43(6):527-32. PubMed ID: 24796217
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Emergence of concurrent infections with colistin-resistant ESBL-positive Klebsiella pneumoniae and OXA-23-producing Acinetobacter baumannii sensitive to colistin only in a Romanian cardiac intensive care unit.
    Timofte D; Dan M; Maciuca IE; Ciucu L; Dabija ER; Guguianu E; Panzaru CV
    Eur J Clin Microbiol Infect Dis; 2015 Oct; 34(10):2069-74. PubMed ID: 26239064
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mutant prevention concentration of tigecycline for Acinetobacter baumannii and Klebsiella pneumoniae clinical isolates.
    Choi MJ; Peck KR; Ko KS
    J Antimicrob Chemother; 2015 Feb; 70(2):621-2. PubMed ID: 25304645
    [No Abstract]   [Full Text] [Related]  

  • 17. Isolation and molecular characterization of New Delhi metallo-beta-lactamase-1 producing superbug in Bangladesh.
    Farzana R; Shamsuzzaman S; Mamun KZ
    J Infect Dev Ctries; 2013 Mar; 7(3):161-8. PubMed ID: 23492993
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rapid antimicrobial susceptibility test for identification of new therapeutics and drug combinations against multidrug-resistant bacteria.
    Sun W; Weingarten RA; Xu M; Southall N; Dai S; Shinn P; Sanderson PE; Williamson PR; Frank KM; Zheng W
    Emerg Microbes Infect; 2016 Nov; 5(11):e116. PubMed ID: 27826141
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increasing resistance rate to carbapenem among blood culture isolates of Klebsiella pneumoniae, Acinetobacter baumannii and Pseudomonas aeruginosa in a university-affiliated hospital in China, 2004-2011.
    Zhang X; Gu B; Mei Y; Wen Y; Xia W
    J Antibiot (Tokyo); 2015 Feb; 68(2):115-20. PubMed ID: 25182483
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Emergence of multiple carbapenemase-producing Gram-negative species, colistin-resistant KPC-2-producing Klebsiella pneumoniae ST11, IMP-7-producing Pseudomonas aeruginosa ST357, and OXA-23-producing Acinetobacter baumannii ST1050, in a single patient.
    Nishida S; Ishigaki S; Asahara M; Furukawa T; Ono Y
    Int J Antimicrob Agents; 2018 Oct; 52(4):512-514. PubMed ID: 30318057
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 18.